3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 MonthsBacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neisseriaceae Infections, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, meningitis, meningococcal infection, meningococcal meningitis, nervous system disorderRecruitingPhase 32026-08-10NCT07505836
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 MonthsBacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neisseriaceae Infections, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, meningitis, meningococcal infection, meningococcal meningitis, nervous system disorderRecruitingPhase 32026-08-10NCT07505823
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 MonthsBacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neisseriaceae Infections, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, meningitis, meningococcal infection, meningococcal meningitis, nervous system disorderRecruitingPhase 32026-08-10NCT07505810